UAE Launches AI-Enabled Drug Manufacturing With InSilico Medicine
The UAE is deploying AI to reduce drug manufacturing costs through a project called InSilico Medicine, part of a broader national push to become a hub for AI-driven healthcare.
The UAE has launched InSilico Medicine, an AI-enabled drug manufacturing initiative designed to dramatically reduce pharmaceutical production costs, as reported by @gulf_news. The project uses AI to optimize drug discovery pipelines, predict molecular interactions, and streamline manufacturing processes.
Unlock the full briefing
Get every story in today's briefing, the full archive, and the daily AI intelligence brief.
All stories today
Full archive
Daily brief
Cancel anytime. Payments powered by Stripe.